Last reviewed · How we verify
Hyaluronic acid and silver sulfadiazine
Hyaluronic acid and silver sulfadiazine is a Topical wound care agent / antimicrobial dressing Small molecule drug developed by University of Cagliari. It is currently FDA-approved for Burn wounds, Chronic wounds, Surgical wounds.
Hyaluronic acid provides a moist wound healing environment while silver sulfadiazine delivers broad-spectrum antimicrobial activity to prevent infection.
Hyaluronic acid provides a moist wound healing environment while silver sulfadiazine delivers broad-spectrum antimicrobial activity to prevent infection. Used for Burn wounds, Chronic wounds, Surgical wounds.
At a glance
| Generic name | Hyaluronic acid and silver sulfadiazine |
|---|---|
| Sponsor | University of Cagliari |
| Drug class | Topical wound care agent / antimicrobial dressing |
| Modality | Small molecule |
| Therapeutic area | Dermatology / Wound Care |
| Phase | FDA-approved |
Mechanism of action
Hyaluronic acid is a natural polysaccharide that maintains moisture at the wound site, promoting epithelialization and reducing scarring. Silver sulfadiazine is a topical antimicrobial agent that releases silver ions to inhibit bacterial growth across a wide spectrum of pathogens. Together, they create an optimal environment for wound healing while preventing secondary infection.
Approved indications
- Burn wounds
- Chronic wounds
- Surgical wounds
- Traumatic wounds
Common side effects
- Local irritation or sensitization
- Allergic reaction to silver sulfadiazine
- Discoloration of wound area
Key clinical trials
- Evaluation of the Effectiveness of a Topical Medical Device in Wound Healing and Symptom Relief in the Postoperative Period of Open Excisional Hemorrhoidectomy (The Emor Study) (PHASE4)
- Clinical Investigation to Evaluate the Safety and Performance of ConnettivinaBio Plus Cream Compared to ConnettivinaBio Cream in the Management of Wounds in Patients at High Risk of Infection (NA)
- Effectiveness and Tolerability of Fitostimoline Plus vs Connettivina Bio Plus in Skin Graft
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hyaluronic acid and silver sulfadiazine CI brief — competitive landscape report
- Hyaluronic acid and silver sulfadiazine updates RSS · CI watch RSS
- University of Cagliari portfolio CI
Frequently asked questions about Hyaluronic acid and silver sulfadiazine
What is Hyaluronic acid and silver sulfadiazine?
How does Hyaluronic acid and silver sulfadiazine work?
What is Hyaluronic acid and silver sulfadiazine used for?
Who makes Hyaluronic acid and silver sulfadiazine?
What drug class is Hyaluronic acid and silver sulfadiazine in?
What development phase is Hyaluronic acid and silver sulfadiazine in?
What are the side effects of Hyaluronic acid and silver sulfadiazine?
Related
- Drug class: All Topical wound care agent / antimicrobial dressing drugs
- Manufacturer: University of Cagliari — full pipeline
- Therapeutic area: All drugs in Dermatology / Wound Care
- Indication: Drugs for Burn wounds
- Indication: Drugs for Chronic wounds
- Indication: Drugs for Surgical wounds
- Compare: Hyaluronic acid and silver sulfadiazine vs similar drugs
- Pricing: Hyaluronic acid and silver sulfadiazine cost, discount & access